Monday, February 06, 2023

Informa Connect’s Access USA

Informa Connect’s Access USA
Hybrid Event | March 20-23, 2023, Philadelphia Marriott Downtown

Exclusive Offer – Be sure to use your exclusive promo 23AUSA10 to save 10% off* of your registration

We would like to introduce to you Access USA, industry’s resource for accelerating access, partnerships and collaboration to deliver superior patient outcomes.

What is Access USA? Access USA will unite PAP – Patient Assistance & Access Programs, Hub and Specialty Pharmacy Models East and Rare Disease Innovation & Partnership Summit, three industry-leading access conferences under one roof for one week of collaborative discussions and opportunities to expand your network and establish powerful partnerships.

Who will be there? Join leading bio/pharma manufacturers, impactful non-profit organizations, top-tier hospitals, foremost health clinics, top-notch PBMs, inspiring advocates, prominent specialty pharmacies, highly regarded academics, leading solution providers and more as they unite to tackle the barriers of patient access and take the necessary steps toward ensuring no patient worry about access to care.

What does that mean for you? In one week, meet with hundreds of key stakeholders across the access landscape and benchmark with, learn from and network with leaders paving the way in patient access. Just choose your preferred event and prepare to walk away inspired and armed with the knowledge necessary to drive patient access forward.

Here are just a few can’t miss content highlights from PAP – Patient Assistance & Access Programs. View the full agenda here.
  • State of the Industry: The Changing Landscape of Healthcare Coverage and Access
  • PhRMA Keynote Address
  • Equity Spotlight: Understanding the Importance of Equitable Healthcare, Education and Partnerships
  • Manufacturer PAP Spotlight: Gain Insight on Best Practices and Industry Standards
  • Customizable Track Programming by PAP Legal & Policy, Patient Adherence Strategies or Technology, Innovation & Automation
  • Workshop Breakout – Advocacy Insights to Enhance Patient Care or Partnership and Development to Optimize Patient Access
Here are just a few can’t miss content highlights from Rare Disease Innovation & Partnership Summit. View the full agenda here.
  • Navigate FDA Updates on Rare Disease Product Development
  • Establish and Navigate the Relationship between Industry and Advocacy
  • Advancing Rare Disease Research with Patient Centrality and Precompetitive Approaches – A Screen4Care Case Study
  • Rare Disease Awareness – Delivering Authentic Lived Experiences in a Challenging Regulatory Landscape
  • The 4Ps of Precision Medicine – Patients, Providers, Partners and Pharma
  • Breakout into Tracks – Access and Reimbursement Strategies, Investing and Partnering, and Drug Development and Clinical Innovation
Here are just a few can’t miss content highlights from Hub and Specialty Pharmacy Models East. View the full agenda here.
  • Policy Address – State of the 2023 Industry and Payer Landscape for Industry Trend Updates
  • Hubs Stakeholder Showcase – Opportunities and Challenges in Accelerating Patient Access with Manufacturer, SPP and Consultant Perspectives
  • Copay Landscape – Changes in the Accumulator/Maximizer Landscape and How to Prepare
  • Enforcement Panel – Explore Evolving Regulatory Reform in the Patient Support Services and Hub Models Space
  • Customizable Tracked Programming by Patient Support & Engagement or Digital & Technological Innovation
Exclusive Offer – Choose your preferred event and register today – Be sure to use your exclusive promo 23AUSA10 to save 10% off* of your registration

Informa Connect will see you there!

*Cannot be combined with other offers, promotions or applied to an existing registration. Other restrictions may apply.

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (

No comments:

Post a Comment